Related references
Note: Only part of the references are listed.[89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer
E. J. van Helden et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
First-in-Humans Imaging with 89Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting
Neeta Pandit-Taskar et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Phantom-based image quality assessment of clinical 18F-FDG protocols in digital PET/CT and comparison to conventional PMT-based PET/CT
Silvano Gnesin et al.
EJNMMI PHYSICS (2020)
The Effect of Various β Values on Image Quality and Semiquantitative Measurements in 68Ga-RM2 and 68Ga-PSMA-11 PET/MRI Images Reconstructed With a Block Sequential Regularized Expectation Maximization Algorithm
Lucia Baratto et al.
CLINICAL NUCLEAR MEDICINE (2020)
CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging
Gary A. Ulaner et al.
RADIOLOGY (2020)
Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using 89Zr-DFO-MSTP2109A Anti-STEAP1 Antibody
Jorge A. Carrasquillo et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma
Sarah R. Verhoeff et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
First-in-Human Human Epidermal Growth Factor Receptor 2-Targeted Imaging Using Zr-89-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
Gary A. Ulaner et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Pharmacokinetics, Biodistribution, and Radiation Dosimetry for 89Zr-Trastuzumab in Patients with Esophagogastric Cancer
Joseph A. O'Donoghue et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial
Bob T. Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Phantom, clinical, and texture indices evaluation and optimization of a penalized-likelihood image reconstruction method (Q.Clear) on a BGO PET/CT scanner
Gabriel Reynes-Llompart et al.
MEDICAL PHYSICS (2018)
Repeatability of SUV in Oncologic 18F-FDG PET
Martin A. Lodge
JOURNAL OF NUCLEAR MEDICINE (2017)
89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2-Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer
Gary A. Ulaner et al.
CLINICAL NUCLEAR MEDICINE (2017)
Comparison of Bayesian penalized likelihood reconstruction versus OS-EM for characterization of small pulmonary nodules in oncologic PET/CT
Brandon A. Howard et al.
ANNALS OF NUCLEAR MEDICINE (2017)
Novel penalised likelihood reconstruction of PET in the assessment of histologically verified small pulmonary nodules
Eugene J. Teoh et al.
EUROPEAN RADIOLOGY (2016)
First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake
Neeta Pandit-Taskar et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT
Gary A. Ulaner et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Does a novel penalized likelihood reconstruction of 18F-FDG PET-CT improve signal-to-background in colorectal liver metastases?
Nassim Parvizi et al.
EUROPEAN JOURNAL OF RADIOLOGY (2015)
Phantom and Clinical Evaluation of the Bayesian Penalized Likelihood Reconstruction Algorithm Q.Clear on an LYSO PET/CT System
Eugene J. Teoh et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
Neeta Pandit-Taskar et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Quantitative and Qualitative Intrapatient Comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: Net Uptake Rate for Accurate Quantification
Irina Velikyan et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
PET imaging with 89Zr: From radiochemistry to the clinic
Melissa A. Deri et al.
NUCLEAR MEDICINE AND BIOLOGY (2013)
Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
E. C. Dijkers et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Standardized methods for the production of high specific-activity zirconium-89
Jason P. Holland et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment
M Yao et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Globally convergent image reconstruction for emission tomography using relaxed ordered subsets algorithms
S Ahn et al.
IEEE TRANSACTIONS ON MEDICAL IMAGING (2003)
A concave prior penalizing relative differences for maximum-a-posteriori reconstruction in emission tomography
J Nuyts et al.
IEEE TRANSACTIONS ON NUCLEAR SCIENCE (2002)
Share Paper
